A pharmacokinetic interaction between tacrolimus and nicardipine in a pediatric renal transplant with cytochrome P450 3A loss-of-function genotypes

被引：0
|
作者：
Froger, C. [1 ]
Promis, A. S. [1 ]
Picard, N. [1 ]
Saint-Marcoux, F. [1 ]
Salas, C. [2 ]
Guigonis, V. [2 ]
Woillard, J. B. [1 ]
Laroche, M. L. [1 ]
机构：
[1] Hop Dupuytren, Serv Pharmacol Toxicol & Pharmacovigilance, CRPV, CHU Limoges, Limoges, France
[2] Hop Mere & Enfant, Dept Pediat, CHU Limoges, Limoges, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2013年 / 27卷
关键词：
drug-drug interaction; pharmacogenetics; cytochromes P450; transplantation;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [1] Interaction Between Tacrolimus and Nicardipine in a Pediatric Renal Transplant With Cytochrome P450 3A Loss-of-Function Genotypes
    Promis, A. A.
    Froger, C.
    Laroche, M. L.
    Saint-Marcoux, F.
    Salas, C.
    Guigonis, V
    Woillard, J. B.
    Marquet, P.
    Picard, N.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 658 - 658
  • [2] Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats
    Qin, Xuan
    Lu, Jian
    Wang, Peili
    Xu, Peipei
    Liu, Mingyao
    Wang, Xin
    BIOCHEMICAL PHARMACOLOGY, 2017, 143 : 129 - 139
  • [3] Implementation of Clinical Cytochrome P450 3A Genotyping for Tacrolimus Dosing in a Large Kidney Transplant Program
    Tillman, Emma
    Nikirk, Miley G.
    Chen, Jeanne
    Skaar, Todd C.
    Shugg, Tyler
    Maddatu, Judith P.
    Sharfuddin, Asif A.
    Eadon, Michael T.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (08): : 961 - 967
  • [4] Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism
    Chitnis, Shripad D.
    Ogasawara, Ken
    Schniedewind, Bjoern
    Gohh, Reginald Y.
    Christians, Uwe
    Akhlaghi, Fatemeh
    XENOBIOTICA, 2013, 43 (07) : 641 - 649
  • [5] Interaction of cytochrome P450 3A inhibitors with P-glycoprotein
    Yasuda, K
    Lan, LB
    Sanglard, D
    Furuya, K
    Schuetz, JD
    Schuetz, EG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01): : 323 - 332
  • [6] Anuric renal failure after amlodipine exposure in a transplant recipient treated with tacrolimus despite normal cytochrome p450 3A expression
    Leroy, S.
    Jaqz-Aigrain, E.
    Isapof, A.
    Bensman, A.
    Ulinski, T.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1586 - 1586
  • [7] Pharmacokinetic Interactions of Rolapitant With Cytochrome P450 3A Substrates in Healthy Subjects
    Wang, Xiaodong
    Wang, Jing
    Arora, Sujata
    Hughes, Lorraine
    Christensen, Jennifer
    Lu, Sharon
    Zhang, Zhi-Yi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (04): : 488 - 499
  • [8] Bimodal distribution of renal cytochrome P450 3A activity in humans
    Haehner, BD
    Gorski, JC
    Vandenbranden, M
    Wrighton, SA
    Janardan, SK
    Watkins, PB
    Hall, SD
    MOLECULAR PHARMACOLOGY, 1996, 50 (01) : 52 - 59
  • [9] Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus)
    Wang, Xiaojing
    Yang, Yaqin
    Martinez, Maria-Aranzazu
    Martinez, Marta
    Lopez-Torres, Bernardo
    Martinez-Larranaga, Maria-Rosa
    Wang, Xu
    Anadon, Arturo
    Ares, Irma
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [10] New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacology
    Stevens, Jeffrey C.
    DRUG DISCOVERY TODAY, 2006, 11 (9-10) : 440 - 445
12345